190 related articles for article (PubMed ID: 1939648)
1. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.
Herrmann MA; Hay ID; Bartelt DH; Ritland SR; Dahl RJ; Grant CS; Jenkins RB
J Clin Invest; 1991 Nov; 88(5):1596-604. PubMed ID: 1939648
[TBL] [Abstract][Full Text] [Related]
2. Follicular variant of papillary thyroid carcinoma: genome-wide appraisal of a controversial entity.
Wreesmann VB; Ghossein RA; Hezel M; Banerjee D; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
Genes Chromosomes Cancer; 2004 Aug; 40(4):355-64. PubMed ID: 15188460
[TBL] [Abstract][Full Text] [Related]
3. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
Trovato M; Fraggetta F; Villari D; Batolo D; Mackey K; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity in 73 human thyroid tumors.
Wozniak A; Wiench M; Olejniczak A; Wloch J; Lachinski A; Lange D; Olczyk T; Jarzab B; Limon J
Neuro Endocrinol Lett; 2005 Oct; 26(5):521-5. PubMed ID: 16264407
[TBL] [Abstract][Full Text] [Related]
6. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
[TBL] [Abstract][Full Text] [Related]
7. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
[TBL] [Abstract][Full Text] [Related]
9. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
[TBL] [Abstract][Full Text] [Related]
10. Screening for genetic aberrations in papillary thyroid cancer by using comparative genomic hybridization.
Singh B; Lim D; Cigudosa JC; Ghossein R; Shaha AR; Poluri A; Wreesmann VB; Tuttle M; Shah JP; Rao PH
Surgery; 2000 Dec; 128(6):888-93;discussion 893-4. PubMed ID: 11114620
[TBL] [Abstract][Full Text] [Related]
11. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
[TBL] [Abstract][Full Text] [Related]
12. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
[TBL] [Abstract][Full Text] [Related]
13. [Loss of heterozygosity on chromosome 3p in thyroid tumors].
Hu MJ; Xu HD; Zhou R; Li XF; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2008 May; 37(5):305-8. PubMed ID: 18956647
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell.
Migdalska-Sęk M; Czarnecka KH; Kusiński M; Pastuszak-Lewandoska D; Nawrot E; Kuzdak K; Brzeziańska-Lasota E
Mol Diagn Ther; 2019 Jun; 23(3):369-382. PubMed ID: 30747408
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.
Aldred MA; Ginn-Pease ME; Morrison CD; Popkie AP; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang SM; Plass C; Eng C
Cancer Res; 2003 Jun; 63(11):2864-71. PubMed ID: 12782592
[TBL] [Abstract][Full Text] [Related]
18. Karyotypic characterization of papillary thyroid carcinomas.
Roque L; Nunes VM; Ribeiro C; Martins C; Soares J
Cancer; 2001 Nov; 92(10):2529-38. PubMed ID: 11745186
[TBL] [Abstract][Full Text] [Related]
19. Genetic alteration mapping on chromosome 7 in primary breast cancer.
Bièche I; Khodja A; Driouch K; Lidereau R
Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity in follicular and papillary thyroid carcinomas.
Rodrigues-Serpa A; Catarino A; Soares J
Cancer Genet Cytogenet; 2003 Feb; 141(1):26-31. PubMed ID: 12581895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]